Weekly Recap | Caris Life Sciences +23.17%, insider sale fails to dent rallyWeekly Review·Sep 19 at 05:44 AMCAI+0.38%
Weekly Recap | Caris Life Sciences -2.91%, most brokers rate it buyWeekly Review·Sep 12 at 07:49 AMCAI+0.38%
